US health authorities have suspended the license for the Ixchiq vaccine against the chikungunya virus following reports of “serious adverse events,” the drug’s French maker said Monday.
This article was originally published on MedicalXpress.com
US suspends chikungunya vaccine Ixchiq over ‘serious’ side effects: Valneva
You may also be interested in:
The Latest
Why stress-related illness is so hard to diagnose, and how a patient-centred playful approach can help
For at least three decades, researchers have gathered evidence that chronic stress puts pressure on the body to constantly adjust itself to restore physiological stability. This process is known as allostatic load and it creates a cascade […]
The Latest
Will a nutritional supplement help you run better?
Whether you jog to keep fit or compete in marathons, the physically demanding sport of running can deplete the body of essential nutrients. During a race like a half-marathon, a runner’s metabolism — or ability […]
The Latest
The Key to a Strong Relationship? Communication
Effective communication is the foundation of any strong, healthy relationship. This article will explore the key elements required to build better communication between partners. We’ll cover the importance of active listening, using empathy and understanding […]
Read More:
-
Making a smoothie, going for an evening walk, or having empathy for a loved one are all examples of executive functions that are controlled by [...]
-
A recent systematic review and meta-analysis conducted by researchers from the Research Institute of the McGill University Health Center (The Institute) and published in eClinicalMedicine [...]
-
With parents and teachers preparing for the return to classroom routines, Brock experts say fostering students’ physical and mental health is key for maximum learning [...]
